PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trial reveals benefits of inhaled nitric oxide for patients with respiratory failure due to COVID-19 pneumonia

Treatment improved blood oxygen levels and lowered the risk of long-term sensory and motor neurologic symptoms

2023-10-06
(Press-News.org) Key Takeaways

Researchers have posted the results of a multisystem phase II clinical trial of patients with COVID-19 and respiratory failure Patients who received inhaled nitric oxide had improved blood oxygen levels and fewer risks of long-term sensory and motor neurologic symptoms They also experienced a faster reduction of viral load in sputum and blood BOSTON – Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.

A recent multicenter international phase II clinical trial led by investigators at Massachusetts General Hospital (MGH) and the University of Alabama in Birmingham (UAB) has revealed that inhaled nitric oxide can benefit patients with respiratory failure due to COVID-19 pneumonia.

The investigator-initiated multi-center trial, which commenced recruitment in March 2020, stands as a testament to the collaborative spirit that prevailed even at the height of the pandemic. The findings are published in the American Journal of Respiratory and Critical Care Medicine.

Prior clinical trials have shown that low-dose (1–20 parts per million) inhaled nitric oxide boosts blood oxygen levels in critically ill patients with acute lung injury.

Low-dose inhaled nitric oxide also improved oxygenation during the severe acute respiratory syndrome (SARS) outbreak of 2003, and recent laboratory experiments showed that nitric oxide inhibits replication of SARS‑CoV‑2.

To test the potential of inhaled nitric oxide gas to treat SARS‑CoV‑2–infected patients who develop lung complications, investigators randomized 193 adults with COVID-19 and respiratory failure who were on ventilators at four hospitals in the United States and one in Sweden to receive high-dose (up to 80 parts per million) nitric oxide for 48 hours or to receive usual care.

Patients who received nitric oxide experienced improved oxygenation and had fewer risks of long-term sensory and motor neurologic symptoms (such as weakness or pain in the extremities) compared with patients receiving usual care.

They also had lower levels of SARS-CoV-2 in their blood and sputum, suggesting that nitric oxide has anti-viral activity. Inhaled nitric oxide was well tolerated and was not linked to any serious adverse events.

Despite these findings, the duration of ventilation and the rates of death at 28 and 90 days did not differ significantly between patients on nitric oxide and those receiving usual care.

“In addition to the well-documented effects on oxygenation, these findings suggest new and promising advantages of utilizing high-concentration inhaled nitric oxide as an antimicrobial agent,” says co–senior author Lorenzo Berra, MD, who is the medical director of Respiratory Care at MGH and the Reginald Jenney Associate Professor of Anaesthesia at Harvard Medical School.

“These results highlight the importance of planning future dose-response investigations into the anti-microbial and clinical properties of high-dose inhaled nitric oxide therapy in adults with acute hypoxemic respiratory failure.”

“The outcomes of this trial will serve as a critical reference for future research, shedding light on specific subgroups like Black and obese individuals, in whom high-dose inhaled nitric oxide may yield more substantial clinical benefits,” said co-senior author Pankaj Arora, MD, director of the Cardiovascular Clinical and Translational Research Program and the Cardiovascular and Genetics Clinic Program at the UAB Marnix E. Heersink School of Medicine.

“This is especially relevant given the underlying suppression and relative deficiency of the nitric oxide-cGMP signaling system in these populations.”

The investigator-initiated multi-center trial, which commenced recruitment in March 2020, stands as a testament to the collaborative spirit that prevailed even at the height of the pandemic.

Additional authors include Raffaele Di Fenza, MD; Naman S Shetty, MD; Stefano Gianni, MD; Vibhu Parcha, MD; Valentina Giammatteo, MD; Bijan Safaee Fakhr, MD; Daniel Tornberg, MD, PhD; Olof Wall, MD, PhD; Piotr Harbut, MD, PhD; Peggy S. Lai, MD; Jonathan Z. Li, MD; Sabrina Paganoni, MD PhD; Stefano Cenci, MD; Ariel L. Mueller, BA; Timothy T. Houle, PhD; Oluwaseun Akeju, MD; Edward A. Bittner, MD PhD; Somnath Bose, MD; Louie K Scott, MD; Ryan W Carroll, MD, MPH; Fumito Ichinose, MD, PhD; and Magnus Hedenstierna, MD.

Each institution provided funding for costs related to the trial.

About the Massachusetts General Hospital

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. MGH is a founding member of the Mass General Brigham healthcare system.

END


ELSE PRESS RELEASES FROM THIS DATE:

nTIDE September 2023 Jobs Report: Employment trend holds steady at historic highs through early autumn for people with disabilities

nTIDE September 2023 Jobs Report: Employment trend holds steady at historic highs through early autumn for people with disabilities
2023-10-06
East Hanover, NJ – October 6, 2023 –The labor force participation and employment-to-population ratio have held relatively steady throughout the summer and into the fall for people with disabilities, while percentages for people without disabilities may have maxed out at their pre-pandemic baseline, according to today’s National Trends in Disability Employment – semi-monthly update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). In comparison, the employment-to-population ratio for people without disabilities remained flat with no change, while ...

Kidney disease gene also has a protective mutation

Kidney disease gene also has a protective mutation
2023-10-06
African Americans have long been known to be at increased risk of kidney disease due to a dangerous genetic mutation that creates a hole in the kidney cells, but Vanderbilt University Medical Center (VUMC) researchers have now discovered a protective genetic mutation that covers the hole to eliminate the risk.   The findings on the apolipoprotein L1 (APOL1) gene, published today in the Journal of the American Society of Nephrology, could have immediate and broad implications for kidney health because people with both the disease-causing and protective mutation are not at increased risk.   “Our team discovered ...

Aston University offers talented Indian graduates opportunity to study for Masters degrees

Aston University offers talented Indian graduates opportunity to study for Masters degrees
2023-10-06
Aston University, UK, is offering a group of highly talented graduates of Symbiosis Institute of Technology (SIT), India the opportunity to study for a Masters degree.   The two institutions have signed a progression agreement which is designed to make it easier for top SIT graduates to apply for courses at Aston University.   The Aston-SIT partnership has been developed from the support of the British Council via its going global partnerships exploratory grant scheme. The areas of study cover a wide range of MSc programmes in engineering, physical sciences and business studies.   Aston University is in Birmingham, ...

New research led by Mays Cancer Center reveals how mutations in BRCA1 affect cancer susceptibility in women

2023-10-06
SAN ANTONIO, Oct. 6, 2023 – Three decades after discoveries linking mutations in the BRCA1 gene to breast and ovarian cancer susceptibility, research led by Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has pinpointed the molecular mechanism by which a large portion of these mutations cause cancers in women. The discovery, unveiled in an Oct. 4 research article in the journal Molecular Cell, is poised to assist researchers in developing drugs to battle breast and ovarian cancers and to help identify women who are at an elevated risk of developing these cancers, according to the ...

How the war in Ukraine is challenging two academic disciplines

How the war in Ukraine is challenging two academic disciplines
2023-10-06
Since the beginning of Russia’s invasion of Ukraine, two academic disciplines have come to fore: peace and conflict studies and East European studies. Experts from both fields represent important voices in the public discourse. A symposium entitled ‘War and Peace in Ukraine: Reflecting, Studying and Engaging Across Disciplines” will be held from 12 until 13 October 2023 at Bielefeld University. It brings together experts from both fields in order to discuss the relationship between them and challenges of participating in a highly ...

How do our brains tell us what went wrong?

2023-10-06
Whether improperly closing a door or shanking a kick in soccer, our brains tell us when we’ve made a mistake because these sounds differ from what we expect to hear. While it’s long been established that our neurons spot these errors, it has been unclear whether there are brain cells that have only one job—to signal when a sound is unexpected or “off.” A team of New York University neuroscientists has now identified a class of neurons—what it calls “prediction-error neurons”—that are not responsive to sounds in general, ...

New pathways of Alzheimer's disease identified

2023-10-06
Dementia, which includes Alzheimer's disease, currently affects around 1.8 million people in Germany. The exact cause has not yet been clarified, but genetic factors play a significant role in the development of the disease.  Most previous analyses aimed at the identification of novel Alzheimer's genes used, a "case-control design". "With this conventional and highly simplistic analysis strategy, a vast amount of clinical information is lost that can be valuable for elucidating new disease mechanisms," says Prof. Dr. Lars Bertram, head of the Lübeck Interdisciplinary Platform for Genome Analysis at the University ...

Consistent metabolism may prove costly for insects in saltier water

2023-10-06
Increased salinity usually spells trouble for freshwater insects like mayflies. A new study from North Carolina State University finds that the lack of metabolic responses to salinity may explain why some freshwater insects often struggle in higher salinity, while other freshwater invertebrates (like mollusks and crustaceans) thrive. Salinity in this case refers to the concentrations of all the salts in an aquatic environment, not just sodium. “Freshwater habitats in general are getting saltier for a number of reasons, including road salt and ...

Clinical trials: two arms are better than one

2023-10-06
The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies. The EMA correctly points out that studies without a control arm are subject to bias and that, in general, it is hardly possible to estimate causal effects from them. However, it does not provide clear criteria for limiting drug approval based on such studies to extremely rare exceptional cases. The FDA shows how to do it There is also no recommendation on external controls - in contrast to guidance published ...

The efficient perovskite cells with a structured anti-reflective layer – another step towards commercialization on a wider scale

The efficient perovskite cells with a structured anti-reflective layer – another step towards commercialization on a wider scale
2023-10-06
Perovskite-based solar cells, widely considered as successors to the currently dominant silicon cells, due to their simple and cost-effective production process combined with their excellent performance, are now the subject of in-depth research. A team of scientists from the Fraunhofer Institute for Solar Energy ISE and the Faculty of Physics at the University of Warsaw presented perovskite photovoltaic cells with significantly improved optoelectronic properties in the journal Advanced Materials and Interfaces. Reducing optical losses in the ...

LAST 30 PRESS RELEASES:

Did lead limit brain and language development in Neanderthals and other extinct hominids?

New study reveals alarming mental health and substance use disparities among LGBTQ+ youth

U.K. food insecurity is associated with mental health conditions

At least eight bat species commute or forage over pig farms in Northern Italy

Ancient teeth reveal mammalian responses to climate change in Southeast Asia

Targeting young adults beginning university may be especially effective for encouraging pro-environmental behaviors

This robotic skin allows tiny robots to navigate complex, fragile environments

‘Metabots’ shapeshift from flat sheets into hundreds of structures

Starting university boosts recycling and greener travel, a University of Bath study finds

How cilia choreograph their “Mexican wave”, enabling marine creatures to swim

Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's

Ancient lead exposure shaped evolution of human brain

How the uplift of East Africa shaped its ecosystems: Climate model simulations reveal Miocene landscape transformation

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

Research alert: Bacterial chatter slows wound healing

American Society of Anesthesiologists names Patrick Giam, M.D., FASA, new president

High-entropy alloy nanozyme ROS biocatalyst treating tendinopathy via up-regulation of PGAM5/FUNDC1/GPX4 pathway

SwRI’s Dr. Pablo Bueno named AIAA Associate Fellow

Astronomers detect radio signals from a black hole tearing apart a star – outside a galactic center

Locking carbon in trees and soils could help ‘stabilize climate for centuries’ – but only if combined with underground storage

New research shows a tiny, regenerative worm could change our understanding of healing

Australia’s rainforests first to switch from carbon sink to source

First-trimester mRNA COVID-19 vaccination and risk of major congenital anomalies

Glucose-lowering medication classes and cardiovascular outcomes in patients with type 2 diabetes

Rising seas and sinking cities signal a coastal crisis in China

Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome

Study indicates dramatic increase in percentage of US adults who meet new definition of obesity

Astrocytes are superstars in the game of long-term memory

WSU study finds positive framing can steer shoppers toward premium products

Study finds ending universal free school meals linked to rising student meal debt and stigma

[Press-News.org] Clinical trial reveals benefits of inhaled nitric oxide for patients with respiratory failure due to COVID-19 pneumonia
Treatment improved blood oxygen levels and lowered the risk of long-term sensory and motor neurologic symptoms